参考文献/References:
[1] Sung H,Ferlay J,Siegel RL,et al.Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2021,71(3):209-249.
[2] 杨子怡,曹 骥,唐艳萍,等.SMARCA4在肝癌组织中的表达及临床意义[J].海南医学,2022,33(9):1095-1098.
[3] Mun J,Hur W,Ku NO.Roles of keratins in intestine[J].Int J Mol Sci,2022,23(14):1-12.
[4] 杭 群,左芦根,骆 杰,等.KRT23在胃癌组织中的表达及其临床意义[J].现代肿瘤医学,2021,29(9):1531-1534.
[5] Kinast V,Leber SL,Brown RJP,et al.Identification of keratin 23 as a hepatitis C virus-induced host factor in the human liver[J].Cells,2019,8(6):1-15.
[6] 杨秉辉,夏景林.原发性肝癌的临床诊断与分期标准[J].中华肝脏病杂志,2001,9(6):324.
[7] 曹永新,陈良才,邓惠君,等.肝癌组织中PFK1的表达及其与手术预后的临床相关性研究[J].深圳中西医结合杂志,2021,31(8):23-25.
[8] 吴许军,李文阳,张甲戌.靶向肝癌抗肿瘤疫苗临床研究进展[J].陕西医学杂志,2022,51(12):1611-1613,1617.
[9] 彭契六,韦尚谋,张 磊,等.miRNA-152在肝癌组织中的表达及临床意义[J].肿瘤防治研究,2021,48(8):769-773.
[10] 庄雪芬,章佳康,李爱民,等.肝癌组织中PD-1表达和微血管生成的关系及临床意义[J].临床肿瘤学杂志,2021,26(3):210-216.
[11] 郭俊霞,魏晓华.乙肝肝硬化患者合并原发性肝癌的危险因素及预后分析[J].陕西医学杂志,2019,48(7):850-852.
[12] 田向永,顾朝辉,贾占奎,等.细胞核增殖抗原、角蛋白7和角蛋白20在膀胱癌组织的表达及临床意义[J].中华实验外科杂志,2017,34(3):497-499.
[13] 许文景,黄冬云,徐兴祥.角蛋白在上皮恶性肿瘤发生、侵袭及转移中的作用[J].癌症进展,2017,15(1):1-3.
[14] 周锦宏,崇 杨.CK19、Ki67、CK7在肝细胞癌组织中的表达[J].肝脏,2022,27(8):887-890.
[15] Lim Y,Ku NO.Revealing the roles of keratin 8/18-associated signaling proteins involved in the development of hepatocellular carcinoma[J].Int J Mol Sci,2021,22(12):6401.
[16] 边 倩,曹 妮,刘 航,等.益脾养肝方对大鼠肝癌癌前病变miR-221表达的影响[J].陕西中医,2020,41(11):1515-1519.
[17] Karsch S,Büchau F,Magin TM,et al.An intact keratin network is crucial for mechanical integrity and barrier function in keratinocyte cell sheets[J].Cell Mol Life Sci,2020,77(21):4397-4411.
[18] 任 梦,高 燕,陈 琪,等.角蛋白在肿瘤诊断及预后中的应用[J].国际肿瘤学杂志,2020,47(6):360-363.
[19] Ren M,Gao Y,Chen Q,et al.The overexpression of keratin 23 promotes migration of ovarian cancer via epithelial-mesenchymal transition[J].Biomed Res Int,2020,2020:8218735.
[20] Kim D,Brocker CN,Takahashi S,et al.Keratin 23 is a peroxisome proliferator-activated receptor alpha-dependent,MYC-amplified oncogene that promotes hepatocyte proliferation[J].Hepatology,2019,70(1):154-167.
[21] 郑曰燕,龚时鹏,陈绍呈,等.角蛋白23在肿瘤中的研究进展[J].广东医学,2019,40(S1):220-222.
[22] Zhang N,Zhang R,Zou K,et al.Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth[J].Cell Death Dis,2017,8(7):1-11.
相似文献/References:
[1]张慧贤,马向明,付庆江,等.肝细胞癌患者血清IL-17细胞因子水平检测的临床意义[J].陕西医学杂志,2016,(10):1394.
[2]苏艳丽,冯 军.血栓弹力图和常规凝血四项检测在评估肝癌患者围术期凝血功能中的应用研究*[J].陕西医学杂志,2019,(7):846.
SU Yanli,FENG Jun..Application of thromboelastography and conventional coagulation in evaluating perioperative coagulation function in patients with liver cancer[J].,2019,(6):846.
[3]李玉龙,宗 伟,常素娥,等.微小RNA-195通过靶向BIRC5调控肝癌Hep3B细胞凋亡实验研究[J].陕西医学杂志,2022,51(3):270.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.002]
LI Yulong,ZONG Wei,CHANG Su'e,et al.Experimental study of miRNA-195 regulating apoptosis of hepatoma Hep3B cells by targeting BIRC5[J].,2022,51(6):270.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.002]
[4]吴许军,李文阳,张甲戌.靶向肝癌抗肿瘤疫苗临床研究进展[J].陕西医学杂志,2022,51(12):1611.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.034]
WU Xujun,LI Wenyang,ZHANG Jiaxu.Clinical research progress of targeted anti-tumor vaccines for hepatocellular carcinoma[J].,2022,51(6):1611.[doi:DOI:10.3969/j.issn.1000-7377.2022.12.034]
[5]曹振振,韩会会,杨文义.肝癌患者血清成纤维细胞生长因子21和富亮氨酸α2糖蛋白1表达情况及临床意义[J].陕西医学杂志,2023,52(3):305.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.013]
CAO Zhenzhen,HAN Huihui,YANG Wenyi.Expression of FGF21 and LRG1 in serum of patients with hepatocellular carcinoma and its clinical diagnostic value[J].,2023,52(6):305.[doi:DOI:10.3969/j.issn.1000-7377.2023.03.013]
[6]濮忠建,杨 军,杨 帆,等.基于长链非编码RNA HOX转录反义RNA探讨次乌头原碱对人肝癌SK-Hep-1细胞自噬的影响实验研究[J].陕西医学杂志,2024,(6):754.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.007]
PU Zhongjian,YANG Jun,YANG Fan,et al.Effect of protopine on autophagy in human liver cancer SK-Hep-1 cells based on lncRNA HOTAIR[J].,2024,(6):754.[doi:DOI:10.3969/j.issn.1000-7377.2024.06.007]
[7]吴 洁,田鑫越,秦耐宇,等.艾司氯胺酮对肝癌细胞恶性生物学行为的影响及作用机制实验研究[J].陕西医学杂志,2024,(8):1041.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.007]
WU Jie,TIAN Xinyue,QIN Naiyu,et al.Effect of esketamine on malignant biological behavior of hepatocellular carcinoma cells and its mechanism[J].,2024,(6):1041.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.007]